Journal profile · Engineering, Biomedical
Clinical Biomechanics
ISSN 0268-0033 · eISSN 1879-1271 · Elsevier Ltd · ENGLAND · Monthly · Founded 1986
Clinical Biomechanics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.81; hybrid open access; APC about USD 2,980; median 168 days to acceptance (115 articles, last 24 months); community-reported acceptance: easy; 246 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Biomechanics is published by Elsevier Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lower Extremity Biomechanics and Pathologies, Total Knee Arthroplasty Outcomes and Balance, Gait, and Falls Prevention, together about 23.6% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
A journal affiliated to the International Society of Biomechanics, the American Society of Biomechanics, the European Society of Biomechanics, the Taiwanese Society for Biomechanics and the Société de Biomécanique.Clinical Biomechanics is an international multidisciplinary journal of biomechanics with a focus on medical and clinical applications of new knowledge in the field.The science of biomechanics helps explain the causes of cell, tissue, organ and body system disorders, and supports clinicians in the diagnosis, prognosis and evaluation of treatment methods and technologies. Clinical Biomechanics aims to strengthen the links between laboratory and clinic by publishing cutting-edge biomechanics research which helps to explain the causes of injury and disease, and which provides evidence contributing to improved clinical management.A rigorous peer review system is employed and every attempt is made to process and publish top-quality papers promptly.Clinical Biomechanics explores all facets of body system, organ, tissue and cell biomechanics, with an emphasis on medical and clinical applications of the basic science aspects. The role of basic science is therefore recognized in a medical or clinical context. The readership of the journal closely reflects its multi-disciplinary contents, being a balance of scientists, engineers and clinicians.The contents are in the form of research papers, brief reports, review papers and correspondence, whilst special interest issues and supplements are published from time to time.Disciplines covered include biomechanics and mechanobiology at all scales, bioengineering and use of tissue engineering and biomaterials for clinical applications, biophysics, as well as biomechanical aspects of medical robotics, ergonomics, physical and occupational therapeutics and rehabilitation.The journal is affiliated to the European Society of Biomechanics, the American Society of Biomechanics, the International Society of Biomechanics, the Taiwanese Society of Biomechanics, and the Société de Biomécanique.
From the journal's Aims & Scope
Research area (LetPub): Engineering, Biomedical
Editorial board by country: 4 in mainland China (about 13%); most named United Kingdom 7, France 5, Mainland China 4, United States 2, Israel 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lower Extremity Biomechanics and PathologiesEngineering8.3%
- Total Knee Arthroplasty OutcomesMedicine8%
- Balance, Gait, and Falls PreventionHealth Professions7.3%
- Musculoskeletal pain and rehabilitationMedicine6.6%
- Knee injuries and reconstruction techniquesMedicine5.8%
- Spine and Intervertebral Disc PathologyMedicine5.3%
- Orthopaedic implants and arthroplastyMedicine5.2%
- Muscle activation and electromyography studiesEngineering5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
| Minor | Orthopedics | Zone 4 |
| Minor | Sport Sciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
| Minor | Orthopedics | Zone 4 |
| Minor | Sport Sciences | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Engineering, Biomedical | Zone 4 |
| Minor | Orthopedics | Zone 4 |
| Minor | Sport Sciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.81LetPub ·
- Impact factor (publisher)
- 1.8Publisher website ·
- CiteScore 2026-06
- 2.9LetPub ·
- CiteScore (publisher)
- 2.9Publisher website ·
- SJR 2026-06
- 0.53LetPub ·
- SNIP 2026-06
- 0.96LetPub ·
- h-index
- 115LetPub ·
- h-index
- 187OpenAlex ·
- i10-index
- 3,823OpenAlex ·
- 2-year mean citedness
- 1.68OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 24.79%LetPub ·
Volume
- Articles per year
- 229LetPub ·
Articles by year OpenAlex count · 6,377 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 180 | 85 | 25 |
| 2025 | 246 | 132 | 359 |
| 2024 | 187 | 106 | 647 |
| 2023 | 210 | 94 | 1,200 |
| 2022 | 214 | 79 | 1,648 |
| 2021 | 212 | 83 | 1,999 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
168 daysMedian, submission to acceptance · P25–P75 128 days – 212 days
- Acceptance to online
- median 2 days (115 articles)
- Submission to online
- median 169 days
- Sample
- 115 articles with submission and acceptance dates (473 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 85 daysPublisher website ·
- Submission to acceptance
- 148 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,980 / EUR 2,790 / GBP 2,390 / JPY 369,610 | — | — | |
| Publisher website | USD 2,750 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 4,000 words
- Highlights
- Required
Article types accepted11, with length limits
- book reviewReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …main text ≤ 1,000 words
- editorialReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …Length not stated
- hypothesisReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …Length not stated
- letterReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …Length not stated
- letters to the editortion from the Book Review Editor only). Letters to the Editor Normally no longer than 1000 words. Note All of the above word limit is for the manuscript texmain text ≤ 1,000 words
- original articleReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …main text ≤ 250 words · abstract ≤ 250 words
- original articlesOriginal Articles typically explore an explicit biological hypothesis or report original, substantial observations or datasets of broad utility.Length not stated
- perspectiveReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …main text ≤ 3,000 words
- reviewReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …main text ≤ 6,000 words
- review articleReviewsNormally 4000 to 6000 words (by invitation from the Editor only). Please note that a prior approval from the Editors in Chief of the Journal is required …Length not stated
- short communication, such articles are by invitation only. Short Communications Up to 2000 words, reporting preliminary observations, new interpretations ofmain text ≤ 2,000 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Elsevier's Publishing Ethics Policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1986
- ISSN
- 0268-0033
- Electronic ISSN
- 1879-1271
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical Biomechanics
What CAS zone is Clinical Biomechanics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Biomechanics is in Zone 4 of Medicine, and in Zone 4 of the minor category Engineering, Biomedical / Orthopedics / Sport Sciences. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Biomechanics?
The latest impact factor listed by LetPub is 1.81; CiteScore 2.9, h-index 187.
How long does peer review take at Clinical Biomechanics?
Based on the dates recorded on 115 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 168 days (interquartile range 128–212 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical Biomechanics?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 4,000 words; Highlights: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical Biomechanics based?
Of the 31 board members whose country the journal's board page names, 4 (about 13%) are in mainland China; the countries named most often are United Kingdom (7), France (5) and Mainland China (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Biomechanics?
According to LetPub and DOAJ records, Clinical Biomechanics is indexed in SCIE and Scopus.
Is Clinical Biomechanics open access, and what is the APC?
Clinical Biomechanics is a hybrid journal. For open-access publication: APC about USD 2,980.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .